Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Lin

Showing results (121-130 of 287) with videos related to

Pageof 29
Sort By:
Clinical Genitourinary Cancer|April 2, 2018
Disparities in Access and Regionalization of Care in Testicular CancerLiam C Macleod, Shannon S Cannon, Oliver Ko, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2016
Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous TestosteroneArthi Thirumalai, Lori A Cooper, Katya B Rubinow, et al.
Urology|January 31, 2026
Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancerMehmet A Bilen, Neal Shore, Sabree Burbage, et al.
European Urology Focus|December 7, 2025
Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 MutationsHeather H Cheng, Sam Callis, Evan Y Yu, et al.
The Journal of Clinical Endocrinology and Metabolism|December 24, 2010
Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trialStephanie T Page, Daniel W Lin, Elahe A Mostaghel, et al.
Genome Research|August 5, 2011
Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexityStacia K Wyman, Emily C Knouf, Rachael K Parkin, et al.
European Urology|October 25, 2012
Contemporary grading for prostate cancer: implications for patient careFadi Brimo, Rodolfo Montironi, Lars Egevad, et al.
Urology|April 15, 2008
Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancerBruce Montgomery, Philip Lavori, Mark Garzotto, et al.
American Journal of Epidemiology|October 24, 2008
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trialAlan R Kristal, Jeannette M Schenk, YoonJu Song, et al.
Journal of the National Cancer Institute|May 10, 2025
Reduced adipose tissue with limited loss of lean mass after weight loss: results from the Prostate Active Lifestyle StudyJeannette M Schenk, Roman Gulati, Sarah J Beatty, et al.
Pageof 29

Showing results (121-130 of 287) with videos related to

Sort By:
Pageof 29
Clinical Genitourinary Cancer|April 2, 2018
Disparities in Access and Regionalization of Care in Testicular CancerLiam C Macleod, Shannon S Cannon, Oliver Ko, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2016
Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous TestosteroneArthi Thirumalai, Lori A Cooper, Katya B Rubinow, et al.
Urology|January 31, 2026
Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancerMehmet A Bilen, Neal Shore, Sabree Burbage, et al.
European Urology Focus|December 7, 2025
Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 MutationsHeather H Cheng, Sam Callis, Evan Y Yu, et al.
The Journal of Clinical Endocrinology and Metabolism|December 24, 2010
Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trialStephanie T Page, Daniel W Lin, Elahe A Mostaghel, et al.
Genome Research|August 5, 2011
Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexityStacia K Wyman, Emily C Knouf, Rachael K Parkin, et al.
European Urology|October 25, 2012
Contemporary grading for prostate cancer: implications for patient careFadi Brimo, Rodolfo Montironi, Lars Egevad, et al.
Urology|April 15, 2008
Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancerBruce Montgomery, Philip Lavori, Mark Garzotto, et al.
American Journal of Epidemiology|October 24, 2008
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trialAlan R Kristal, Jeannette M Schenk, YoonJu Song, et al.
Journal of the National Cancer Institute|May 10, 2025
Reduced adipose tissue with limited loss of lean mass after weight loss: results from the Prostate Active Lifestyle StudyJeannette M Schenk, Roman Gulati, Sarah J Beatty, et al.
Pageof 29